Table 1.

Participant Characteristics

Characteristic	Total (N = 16)
Age, mean (range), years	53.8 (46–64)
Male, n (%)	8 (50)
Race/ethnicity, n (%)
White	6 (38)
Hispanic	9 (56)
Black	1 (6)
Time since la/mUC diagnosis, mean (range), months	2.73 (1–5)
Type of urothelial carcinoma, n (%)
Metastatic	6 (38)
Locally advanced	10 (63)
Treatments, n (%)
Cisplatin and gemcitabine	3 (19)
MVAC (methotrexate, vinblastine, doxorubicin, and cisplatin)	9 (56)
Paclitaxel, cisplatin, and gemcitabine	2 (13)
Carboplatin and gemcitabine	2 (13)
Worst pain in past week, mean (range)	6.2 (3–10)

la/mUC locally advanced or metastatic urothelial carcinoma.